ArticleMicrobial cell factories2026
Catalytically active inclusion bodies of Bacillus clausii laccase protein recombinantly produced in E. coli for dye decolorization.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionPollution causes disease and premature death globally. Various strategies, including biological methods like enzymes, are used to treat pollutants. The production of recombinant proteins in E. coli often results in their aggregation as inclusion bodies (IBs), enriched with the protein of interest. We developed a novel strategy for producing an immobilized bacterial laccase through self-assembly into catalytically active IBs (CatIBs) in E. coli. Our target was the outer spore-coat protein CotA from Bacillus clausii, a halotolerant and pH-stable laccase suitable for scalable applications in wastewater treatment. Two constructs were designed: Lac-17 (without fusion tags) and Lac-40EL (fused to a synthetic 35-amino-acid peptide, named as 40EL), both expressed in E. coli BL21(DE3).
resultsBoth strains showed similar growth patterns, though Lac-17 yielded more total recombinant protein (~ 163 mg/L vs. ~127 mg/L). However, Lac-40EL formed CatIBs with up to 22-fold higher enzymatic activity than Lac-17, despite ~ 85% of the recombinant protein being in the insoluble fraction in both cases. Structural models suggest that the 40EL peptide forms an exposed double α-helix that promotes ordered aggregation without hindering the active site of the enzyme. Unlike the soluble fractions, the CatIBs retained their activity after three months at 4 °C. In azo dye decolorization assays with Eriochrome Black T and Congo Red, Lac-40EL CatIBs outperformed Lac-17, particularly in the presence of redox mediators.
conclusionsThis work shows that rational peptide design can improve enzyme immobilization, activity, and stability through CatIBs formation. The resulting CatIBs self-assembled efficiently, were easily recovered, and demonstrated operational stability, supporting their potential for scalable production and novel applications in textile wastewater treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.